ArticleRheumatology (Oxford, England)2019

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.

Karen M Fagerli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.